454
Views
2
CrossRef citations to date
0
Altmetric
Drug Profile

A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022

, , , , , & show all
Pages 457-469 | Received 11 Mar 2022, Accepted 20 Apr 2022, Published online: 03 May 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.